Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-07-26, Stock:PFE, The news for the past five days is as follows:
2021-07-19: NEWS1: Pfizer (PFE) Stock Moves -0.5%: What You Should Know.NEWS2: ‘Vaccination is really our route out of this pandemic’: Doctor.NEWS3: The spread of misinformation is a 'globalized, anti-vaccine, anti-science empire:' Expert.NEWS4: Covid-19 hospitalizations rise among unvaccinated.NEWS5: More athletes test positive for Covid days ahead of Olympics.NEWS6: Why the market can’t afford to ignore the COVID Delta variant.NEWS7: Japan Health Ministry Supports Lowering Minimum Age For Moderna's COVID-19 Vaccine To 12 Years.NEWS8: Pfizer says FDA's decision to approve its COVID-19 vaccine is expected by January.NEWS9: Delta variant: 'We’re going to see breakthrough cases' and that's OK, doctor says.NEWS10: FDA Supports Limited Distribution Of Pfizer's Antismoking Pill, Chantix.NEWS11: Introducing Pfizer (NYSE:PFE), A Stock That Climbed 11% In The Last Year.NEWS12: Merck's Pneumococcal Vaccine Lands FDA Nod, Just Few Weeks After Its Rival.NEWS13: Pfizer Announces New Investor Relations Leader.NEWS14: UK rules out universal vaccination for teenagers for now.
2021-07-20: NEWS1: UPDATE 5-Australia, under lockdown, sees worrying jump in COVID-19 cases.NEWS2: JNJ Option Traders Ready for Positive Earnings.NEWS3: ‘Likelihood of reaching herd immunity at this point is fairly low’: Epidemiologist.NEWS4: Immunity provided by COVID-19 vaccines likely to ‘wane, not plummet,’ CDC director tells Congress.NEWS5: Immunity from the COVID-19 vaccines likely to ‘wane, and not plummet,’ CDC director tells Congress.NEWS6: Vaccine Makers Gain After Fox News Anchors Become Jab Supporters.NEWS7: 3 Areas Where Pfizer Is Crushing Moderna.NEWS8: FOCUS-Global quest underway to speed COVID-19 vaccine trials.NEWS9: Are Booster Doses of Pfizer's and Moderna's COVID Vaccines on the Way?.NEWS10: Have $3,000? 2 Smart Growth Stocks to Buy Right Now.
2021-07-21: NEWS1: South African company to start making Pfizer vaccine.NEWS2: Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds.NEWS3: Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings.NEWS4: Why BioNTech Stock Jumped Today.NEWS5: Pfizer (PFE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release.NEWS6: ‘It’s very premature to talk about booster vaccines’: Doctor.NEWS7: J&J COVID-19 vaccine sales to total  $2.5 billion in 2021.NEWS8: UPDATE 1-South African firm to help make Pfizer/BioNTech COVID vaccine.NEWS9: Norway, Lithuania swap J&J, Pfizer vaccines to speed up inoculation.NEWS10: The World Is Squandering Vaccines as New Wave Starts, WHO Chief Says.NEWS11: Pfizer, BioNTech partner with South African drug maker to make and distribute COVID-19 shot in Africa.NEWS12: Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa.NEWS13: Pfizer/BioNTech strike South Africa COVID-19 manufacturing deal with Biovac.NEWS14: J&J forecasts $2.5 billion in 2021 COVID-19 vaccine sales, sets lower production target.NEWS15: UPDATE 5-J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target.NEWS16: J&J raises revenue forecast, estimates $2.5 billion in COVID-19 vaccine sales.NEWS17: Will Pfizer Be Worth More Than Tesla by 2025?.NEWS18: J&J Gains On Revising Guidance After Medical Devices Boost In Q2.
2021-07-22: NEWS1: Australia's drug regulator approves Pfizer COVID-19 vaccine for 12 to 15-year-olds.NEWS2: Spacing Pfizer COVID shots boosts antibody levels after initial drop -study.NEWS3: UPDATE 1-U.S. CDC advisers mull COVID-19 boosters for immune-compromised people.NEWS4: Why Arvinas Jumped 10% Today.NEWS5: Column: Here's why the FDA shouldn't rush giving full approval to the COVID vaccines.NEWS6: ‘We haven’t seen the high consequence variants yet’: Doctor.NEWS7: CDC advisers consider boosters for immune-compromised Americans.NEWS8: Healthcare ETFs in Focus as Q2 Earnings Unfold.NEWS9: Why the Delta variant is so dangerous for the unvaccinated.NEWS10: The FDA may not fully approve a COVID-19 vaccine until January. Here’s why..NEWS11: Pfizer (PFE) Inks Vaccine Deal, Faces FDA Delay on JAK Drugs.NEWS12: 2 Dirt Cheap Dividend Stocks You Can Buy Right Now.NEWS13: Pfizer to pay at least $1 billion to develop, commercialize Arvinas' investigational breast-cancer therapy.NEWS14: FDA Will Not Meet Goal Dates For Pfizer's Xeljanz, Abrocitinib Applications.NEWS15: How Big of an Impact Will COVID-19 Have on the Stock Market Going Forward?.NEWS16: Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471.NEWS17: Arvinas Stock Surges on Pfizer Breast Cancer Treatment Deal.NEWS18: How in the World Is Moderna Valued at More Than Half of Pfizer's Market Cap?.NEWS19: WRAPUP 9-Olympics-Opening ceremony director fired on Tokyo Games eve over Holocaust joke.
2021-07-23: NEWS1: Doctor on the Olympics regarding COVID-19: ‘There are a lot of concerns’.NEWS2: 10 Best Dividend Contenders to Buy in 2021.NEWS3: This is the tipping point for when people vaccinated against COVID-19 should mask up again indoors.NEWS4: Booster Shots Seem More Likely. Israeli Data Show Delta Variant’s Risks..NEWS5: Pfizer vaccine 39% effective against Delta variant, NFL COVID outbreaks, Kanye West debuts new 'Donda' album.NEWS6: Arvinas (ARVN), Pfizer Team up for Breast Cancer Therapy.NEWS7: Will Pfizer (PFE) Beat Expectations This Earnings Season?.NEWS8: Why This Company’s Covid-19 Vaccine Is Just the Beginning.NEWS9: Pfizer and BioNTech to Supply U.S. With 200 Million COVID Shots.NEWS10: EU Drugs Regulator Recommends Moderna Shot for Teenagers.NEWS11: UPDATE 1-Spacing Pfizer COVID shots boosts antibody levels in long-term study.NEWS12: Pharma Stock Roundup: JNJ, NVS Q2 Earnings, PFE, ABBV, LLY & MRK FDA Updates.NEWS13: UPDATE 4-United States buys 200 mln more doses of Pfizer/BioNTech COVID-19 vaccine.NEWS14: Pfizer and BioNTech to supply U.S. govt with additional 200 million doses of COVID-19 vaccine.NEWS15: Pfizer says U.S. govt buys 200 mln more doses of COVID-19 vaccine.NEWS16: Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S..NEWS17: Is It Too Late to Buy Moderna Stock?.NEWS18: Why BioNTech, Moderna, and Novavax Stocks Soared This Week.NEWS19: Can Today's Vaccines Beat the Delta Variant?.NEWS20: Japan PM seeks faster COVID vaccine delivery from Pfizer- media.NEWS21: Pfizer's Inc. (NYSE:PFE) Dividend is Depending on Vaccine Booster Shots.NEWS22: US buys 200m Pfizer jabs for children and possible boosters.NEWS23: US seals deal for another 200m doses of Pfizer’s Covid vaccine.

Answer: Rise